Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
|
|
Articles |
|
|
Delivery logistics is critical to COVID-19 vaccine availability.
The opening months of 2021 have revealed the logistical and political intricacies of COVID-19 vaccine manufacturing and deployment. The unprecedented requirement of vaccinating the world against...
|
|
|
|
|
| |
|
|
|
Meeting Future Global Healthcare Needs with Manufacturing 4.0.
The COVID-19 pandemic has brought unprecedented attention to the speed at which drugs are developed, tested, manufactured, and distributed.
|
|
|
|
Latest News & Press Releases |
|
|
Moderna and Medison Pharma Partner to Commercialize COVID-19 Vaccine Across Central Eastern Europe and Israel.
Moderna and Medison Pharma, a leading commercial partner for highly innovative therapies in international markets, announced a new agreement to Moderna...
|
|
|
|
| | |
|
| |
|
|
|
AGC Biologics Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine.
AGC Biologics has announced its partnership with BioNTech SE to further supply Plasmid DNA starting material for the Pfizer-BioNTech COVID-19 vaccine...
|
|
|
| |
|
INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate.
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases....
|
|
|
|
| | |
|
| |
|
|
|
'Black Mould' [Mucormycosis] – the Dark Side of At home and Self-COVID-19 Treatment
In fact, it's not just this particular bug that we need to be concerned about. There are other cousins of mucor lurking in our environment, waiting for the perfect...
|
|
|
| |
|
mCureX and Samyang sign MoU for mRNA vaccine development.
mCureX has entered a memorandum of understanding with Samyang Holdings to develop a messenger ribonucleic acid vaccine for Covid-19.....
|
|
|
|
|